The data shows the top 5 global vaccine products based on their revenues worldwide in 2017, and a projection for 2024. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate some 5.76 billion USD in revenues by 2024. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Top vaccine products
Vaccines act as a preventive measure to improve immunity to certain diseases.
